Lihua brings previous experience from Ra Pharma and UCB. She specializes in mRNA display and in vitro selection platform drug discovery, successfully delivering target binders from hit campaigns, designing and conducting hit selection data analysis and developing and implementing assays to characterize binders for down-selection. She has a B.S. in biological sciences from Beijing Forestry University, an M.S. in plant biology from Fudan University and a Ph.D. in plant biology from Pennsylvania State University.